A significant body of research demonstrated a strong correlation between transaminase levels and MASLD risk factors, including obesity, dyslipidemia, and elevated insulin levels (Lin et al., 2022; Ma et al., 2019). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.